sumatriptan: be in supply

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.54
, agent
Weight: 0.49
, medication
Weight: 0.44
Siblings acetaminophen
Weight: 0.34
, ibuprofen
Weight: 0.34
, thalidomide
Weight: 0.34
, vancomycin
Weight: 0.33
, metronidazole
Weight: 0.33

Related properties

Property Similarity
be in supply 1.00
be in short supply 0.93

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.25
Rule weight: 0.28
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.65
Plausible(sumatriptan, be in supply) ⋁
Evidence: 0.36
¬ Salient(sumatriptan, be in supply)

Similarity expansion

0.72
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.93
Evidence: 0.65
Plausible(sumatriptan, be in supply) ⋁
Evidence: 0.25
¬ Plausible(sumatriptan, be in short supply)
0.71
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.93
Evidence: 0.10
Typical(sumatriptan, be in supply) ⋁
Evidence: 0.12
¬ Typical(sumatriptan, be in short supply)
0.61
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.93
Evidence: 0.71
Remarkable(sumatriptan, be in supply) ⋁
Evidence: 0.77
¬ Remarkable(sumatriptan, be in short supply)
0.61
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.93
Evidence: 0.36
Salient(sumatriptan, be in supply) ⋁
Evidence: 0.36
¬ Salient(sumatriptan, be in short supply)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.36
Salient(sumatriptan, be in supply) ⋁
Evidence: 0.10
¬ Typical(sumatriptan, be in supply) ⋁
Evidence: 0.71
¬ Remarkable(sumatriptan, be in supply)

Typical implies Plausible

0.46
Rule weight: 0.48
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.65
Plausible(sumatriptan, be in supply) ⋁
Evidence: 0.10
¬ Typical(sumatriptan, be in supply)